NSB 0.00% 4.1¢ neuroscientific biopharmaceuticals ltd

Ann: NSB files new patent, page-13

  1. 1,516 Posts.
    lightbulb Created with Sketch. 282
    Patent for Copaxone ceased in 2014 , but pesumbaly the two companies are working together as NSB would need to source Copaxone part of the product or the news story attached (dated 2018) might also explain https://www.fiercepharma.com/pharma/facing-generics-from-mylan-and-novartis-teva-loses-patent-appeal-copaxone "Teva's patent failure gives long-acting Copaxone generics free rein"
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.000(0.00%)
Mkt cap ! $5.928M
Open High Low Value Volume
4.3¢ 4.3¢ 4.0¢ $17.32K 403.9K

Buyers (Bids)

No. Vol. Price($)
2 305000 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 94677 1
View Market Depth
Last trade - 14.34pm 16/08/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.